Clinical Trial Update: Lot Consistency Clinical Trial of of Recombinant HPV Bivalent Vaccine in 9 to14 Years Old Healthy Female [Phase 4]

View source ↗

Summary

Phase 4 trial update assessing lot consistency of recombinant HPV bivalent vaccine in healthy girls aged 9-14; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Cervical Intraepithelial Neoplasia
• Persistent Infection
• Vaginal Intraepithelial Neoplasia
• Vulvar Intraepithelial Neoplasia

Drugs mentioned

• recombinant HPV bivalent vaccine

Snippet

Sponsor: Xiamen Innovax Biotech Co., Ltd | Conditions: Cervical Intraepithelial Neoplasia, Cervical Cancer | Phase 4 | Status: COMPLETED